Timestamps 0:00 A 43-year-old man is getting weaker, not stronger 2:09 Taking the history: Medications, lifestyle, and red flags 12:53 The labs come back: CK at 18,979 16:05 Metabolic syndrome and the modern treatment approach 23:15 Rhabdomyolysis: What it is and why its dangerous 29:50 Final diagnosis and what went wrong with the medications 37:15 2026 ACC lipid guidelines: What changed 40:32 Three mechanisms: How statins affect muscle 47:02 The nocebo effect and the SAMSON trial 54:17 Do statins impair training
Borna Vrdoljak, Departments of Pharmacology and Pathology, Medical Faculty University of Zagreb, Zagreb 10000, Croatia
Ethics declarations Conflict of interest The authors declare no financial or non-financial competing interests
Overtraining increases cortisol and can mute peptide advantages
Outcome Focus: The trials were designed primarily to assess weight loss efficacy, with safety as a secondary outcome
Where can I buy lab grade GHK-Cu in the USA